- Home
- LPL vs CPRX Comparison
LPL vs CPRX Comparison
Compare LPL & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPL
- CPRX
- Stock Information
- Founded
- LPL 1985
- CPRX 2002
- Country
- LPL South Korea
- CPRX United States
- Employees
- LPL N/A
- CPRX N/A
- Industry
- LPL Industrial Machinery/Components
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- LPL Technology
- CPRX Health Care
- Exchange
- LPL Nasdaq
- CPRX Nasdaq
- Market Cap
- LPL N/A
- CPRX 2.6B
- IPO Year
- LPL 2004
- CPRX 2006
- Fundamental
- Price
- LPL $3.16
- CPRX $24.69
- Analyst Decision
- LPL Sell
- CPRX Strong Buy
- Analyst Count
- LPL 2
- CPRX 8
- Target Price
- LPL N/A
- CPRX $32.50
- AVG Volume (30 Days)
- LPL 167.3K
- CPRX 1.5M
- Earning Date
- LPL 04-24-2025
- CPRX 05-07-2025
- Dividend Yield
- LPL N/A
- CPRX N/A
- EPS Growth
- LPL N/A
- CPRX 107.94
- EPS
- LPL N/A
- CPRX 1.31
- Revenue
- LPL $18,016,806,691.00
- CPRX $491,734,000.00
- Revenue This Year
- LPL $2.57
- CPRX $15.17
- Revenue Next Year
- LPL $0.51
- CPRX $8.28
- P/E Ratio
- LPL N/A
- CPRX $18.96
- Revenue Growth
- LPL 24.77
- CPRX 23.49
- 52 Week Low
- LPL $3.05
- CPRX $14.47
- 52 Week High
- LPL $4.86
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- LPL 42.41
- CPRX 62.78
- Support Level
- LPL $3.18
- CPRX $20.68
- Resistance Level
- LPL $3.28
- CPRX $26.16
- Average True Range (ATR)
- LPL 0.07
- CPRX 0.83
- MACD
- LPL -0.00
- CPRX 0.36
- Stochastic Oscillator
- LPL 20.27
- CPRX 75.21
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.